CytoMed Therapeutics Limited
General ticker "GDTC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $26.7M (TTM average)
CytoMed Therapeutics Limited does not follow the US Stock Market performance with the rate: -20.2%.
Estimated limits based on current volatility of 4.0%: low 1.49$, high 1.61$
Factors to consider:
- Total employees count: 28 as of 2022
- Current price 13.9% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.64$, 4.12$]
- 2025-12-31 to 2026-12-31 estimated range: [1.41$, 3.60$]
Short-term GDTC quotes
Long-term GDTC plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $0.05MM |
| Operating Expenses | $2.68MM |
| Operating Income | $-2.63MM |
| Non-Operating Income | $0.74MM |
| Interest Expense | $0.02MM |
| R&D Expense | $1.43MM |
| Income(Loss) | $-1.89MM |
| Profit(Loss)* | $-1.88MM |
| Stockholders Equity | $6.57MM |
| Inventory | $0.61MM |
| Assets | $7.37MM |
| Operating Cash Flow | $-1.69MM |
| Capital expenditure | $1.03MM |
| Investing Cash Flow | $0.49MM |
| Financing Cash Flow | $-0.03MM |
| Earnings Per Share** | $-0.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.